The alleviation of food-borne diseases caused by microbial pathogens remains a great concern in order to ensure the well-being of the general public. The relation between the ingested dose of organisms and the associated infection risk can be studied using dose-response models. Traditionally a model selected according to a goodness-of-fit criterion has been used for making inferences. In this paper we propose a modified set of fractional polynomials as competitive dose-response models in risk assessment. The paper not only shows instances where it is not obvious to single out one best model but also illustrates that model averaging can best circumvent this dilemma. The set of candidate models is chosen based on biological plausibility and rationale and the risk at a dose common to all these models estimated using the selected models and by averaging over all models using Akaike's weights. In addition to including parameter estimation inaccuracy, like in the case of a single selected model, model averaging accounts for the uncertainty arising from other competitive models. This leads to a better and more honest estimation of standard errors and construction of confidence intervals for risk estimates. The approach is illustrated for risk estimation at low dose levels based on Salmonella Typhi and Campylobacter jejuni data sets in humans. Simulation studies indicate that model averaging has reduced bias, better precision and also attains coverage probabilities that are closer to the 95% nominal level compared to best fitting models according to AIC.
Introduction
Human exposure to microorganisms such as yeasts, molds, bacteria, protozoa, helminths (worms) through food and/or water consumption dictates potential risk of food-borne infection or illness if such microbes survive in the human system. The dose exposed to is a measurement of microorganisms in relation to their ability to cause infection or illness. The unit of measurement of the dose is the colony forming unit (cfu). Ensuring food safety is directly proportional to a reduction of infectious or toxic food-borne pathogens. This process involves the identification of the microorganisms, how much of the organism an individual is exposed to and the risk associated with a given dosage. Such relations have been studied using various dose-response models to estimate risks in diverse range of problems. It is indeed very important to provide unbiased risk estimates including uncertainty as much as possible, in order to allow stakeholders (policy makers, producers, consumers) to assess risks as fairly as possible (given the current state of knowledge).
With regard to dichotomous responses, a dose-response model is a function describing the relationship between the dose administered and the probability of infection or disease. In general, any monotonic function which is bounded by zero and one is a possible function for such dose-response relationship. In the literature, several dose-response models have been proposed and they can be categorized into mechanistically and empirically oriented models.
For example, Haas et al. (1999) developed a Beta-Poisson (BP) model from a mechanistic viewpoint where the biological process is readily taken into account. This model, owing to its biological plausibility, has received much attention in many pathogen dose-response studies (Teunis et al., 1996) . It should be noted however that several assumption are made in the biological process which can be questioned. Alternatively, so-called empirical models such as the log-logistic (LL), the log-normal (LN) and the extreme value (EV) models have also been used . Whichever origin the models may have, the conventional way to making inferences has largely been dependent on a single chosen model based on some model selection criterion. Then, one typically proceeds as though that was the only model and thus discards the other possible models and model uncertainty. Using a single selected model ignores variation that arises from other competing models and as a result leads to too small standard errors and narrow confidence intervals which are unrealistically optimistic (Burnham and Anderson 2002) .
Instead of proceeding with one single model, one could argue that each model is a possible candidate dose-response model. Buckland et al. (1997) proposed a way of incorporating the uncertainity that arises from other competitive models by model averaging using Akaike Information Criterion (AIC) weights. The better a model, according to a certain selection criterion, the larger the weight given to this model. This approach is further discussed by Burnham and Anderson (2002) . In the discipline of microbial risk assessment, model averaging has been employed. Bailer et al. (2005) accounted for model uncertainty for experimental studies of quantal responses using a bayesian approach and weighted the models using the bayesian information criterion (BIC). In the frequentist approach model averaging has been used by Kang et al. (2000) to estimate microbial risk using AIC and by Moon et al. (2005) to estimate effective microbial doses for infection and illness using Kullback Information Criterion (KIC). In both papers, a mix of the four aforementioned mechanistically and empirically oriented models is considered. In this paper, a further extension of dose-response modelling is investigated.
It is clear that a flexible dose-response model should be used to describe the data well.
Typically, in the empirically oriented models, a linear dose trend is assumed, which might be too restrictive in the setting of microbial risk assessment. Therefore, we propose to extend the dose-response models by considering fractional polynomials within the family of empirical models. While Royston and Altman (1994) proposed the fractional polynomials as a pre-defined set of (generalized) linear models, we propose a modified set according to a biological rationale. To account for the model-uncertainty in the extended set of possible dose-response models, we estimate the risk to Salmonella typhi and to Campylobacter jejuni data sets by model averaging.
The rest of this paper proceeds with a set of plausible models considered in Section 2, a review of the model averaging approach in Section 3 followed by an application of the method to Salmonella typhi and Campylobacter jejuni data in Section 4 and simulation studies in Section 5. A discussion and concluding remarks in Section 6 wind up the paper.
Microbial Dose-Response Models
The data for microbial risk assessment can be obtained experimentally where dose groups are known or as a result of outbreaks in which the exact ingested dose is not known but can be approximated. The extracted information to study, for instance, dichotomous dose-response relations involves a total number n i of individuals or animals to which a particular dose d i of microbes was administered and out of these it is observed that X i become infected or ill.
To translate this process statistically, X i is assumed to follow a binomial distribution with parameters n i and π(d i ), the latter being the probability that a subject becomes infected (or ill). Dose-response models refer to models for π(d) as a function of d.
Different dose-response models with one, two, and three parameters have been proposed and studied in microbial risk assessment literature (Kodell et al., 2002; Moon et al., 2005) . The inclusion of biological processes gave rise to so-called mechanistic models of which the BetaPoisson (BP) model is the most popular and extensively used one (e.g., Haas et al., 1999) .
However, the adequacy of the BP model as automatic "default" model has been questioned (Marks et al., 1998) . Alternative models such as the so-called log-normal (LN), log-logistic (LL), and the extreme value (EV) model have been suggested (see e.g. Pinsky, 2000) . These latter models are standard generalized linear models (GLM), used in statistics to analyse binary response data. At first sight, they however seem to lack any biological interpretation.
The purpose of this section is to indicate that many models, such as GLM's, could have a biological interpretation, similar to that of the BP model. A basic concept in applied statistics states that the true or correct model is never known (or does even not exist) and that all dose-response models are wrong; they are merely approximations (e.g., Burnham and Anderson, 2002) . So, the best one can do is to use a good approximating model. Now, depending on the setting and the willingness to rely on assumptions or on data or on both, there are three options: i) to select the model in advance, possibly prior to data collection, only based on biological assumptions (e.g., the BP model); ii) to select a final model from a set of candidate models; and iii) to use as a final model a weighted average over all or some candidate models. For option ii) and iii) this set of candidate models may be (partly) inspired or based on biological knowledge and assumptions. In this paper we opt for the model averaging approach, since it incorporates explicitly the process of model selection and thus reflects model uncertainty. A crucial aspect of both options ii) and iii) is the use of a well-defined and rich enough set of candidate models. For that purpose, we consider the family of fractional polynomials (FP) (Royston and Altman, 1994) and propose a modified version of FP's, such that they obey some basic biological constraints. These models together with the BP, LN, LL, and EV model will define our set of candidate models.
A Generic Mechanistic Dose-Response Model
So-called mechanistic dose-response models reflect underlying biological processes involved in the kinetics of microorganisms in the body of a human or animal host, in order to determine the proportion that develop an adverse event, owing to exposure to a source containing infectious microorganisms . The formulation of such models involves different subprocesses.
First of all, let π ing (j|d) be the probability of ingesting j organisms by an individual, from an exposure source of mean dose d. The second subprocess generates the event that k out of j organisms survive to initiate infection. Let π surv|ing (k|j, r) be the probability of such an event, where r is the probability of survival of a single pathogenic organism in a human host. The total probability that k organisms survive to initiate infectious foci is then given
There is uncertainty about the minimal number of surviving organisms, k min , that are needed to initiate infection. For k ≥ 1, denote by π inf,k the probability that k surviving organisms initiate infection. The probability of infection, for a given mean dose d, can then be written
which, when π inf,k equals 1 for k ≥ k min and π inf,k is 0 for k < k min , simplifies to
One can expect different sources of heterogeneity in this approach. The variation in r between hosts and/or between pathogenic organisms can be described by a density π var (r) over the interval [0, 1] , leading to the marginal distribution
Model (3) 
where Γ k min (rd) is the cumulative distribution of an incomplete gamma distribution with parameter k min , evaluated at rd. Taking k min = 1 leads to the exponential model
In some situations, choices and assumptions can be verified separately, such as the Poisson assumption in dose verification studies (see e.g. DuPont et al., 1995) .
Choosing π ing and π surv|ing and k min = 1 as above, but now with π var a beta density, the dose-response relation expressed as a complement of the confluent hypergeometric function
which Furumoto and Mickey (1967) approximated to the popular BP model
provided β α. Teunis and Havelaar (2000) demonstrate that the BP model can produce results similar to the hypergeometric relation, as long as the conditions given by Furumoto and Mickey (1967) are fulfilled. But it is also shown that the BP model might lead to completely different results, which can even be misleading in case very little information is available. See also Teunis et al. (2004) .
From the general mechanistic model (3) many other models can be derived. Choosing π ing as a Poisson random variable with mean µ(d), k min = 1, π var as the point mass distribution
, and π surv|ing as the point mass distribution I [k=j] , we can recover the classical models and the fractional polynomials. Taking, respectively, can not decrease as a function of k). In fact any cumulative distribution function on the integers, having value 0 at k = 0, can play the role. Many choices would however not lead to analytically tractable formula's. But any possible model, whatever choice of different distributions in (3), has some fundamental properties in common: no infection in the case when no pathogenic organisms are ingested; the more organisms ingested, the higher the probability of infection; and an extremely high dose exposure always results in infection; or equivalently, assuming the model is a differentiable function of dose d with derivative
Properties (8) to (10) In Section 4 we illustrate that, depending on the application, additional constraints can or should be added to the minimal set of properties (8) 
to (10).
A crucial concept in the theory of multimodel inference is the fact that a "correct model"
does not exist. Any model is incorrect and merely tries to approximate the true process. It is rather a matter of selecting a good approximating model or, in the approach of multimodel inference, to average over a certain subset of good approximating models, assigning higher weights to better approximating models. In this philosophy it is obviously important to define a rich enough family of candidate models. Here, as indicated in Section 2.2, the family of fractional polynomials have shown to be a well-defined and rich family of models.
All models considered in this paper as candidate models are listed in Table 1 . They are the typical models used in the literature, the aforementioned BP, LL, LN, EV, extended with a new family of fractional polynomial models, as introduced in Section 2.2.
Infection versus Illness
Often the data refer to illness rather than to the infection status of the individual. This is the case for the Salmonella typhi data (Hornick et al., 1970) in Table 2 . These are experimental data on healthy adult volunteers, not exposed previously. Infection was not reported separately, only illness, which was described as developing fever (higher than 103
followed by headaches and abdominal pain. Nevertheless the BP model is typically used for analyzing such illness data. But since
the BP model loses its direct biological interpretability for estimating the illness probability P (illness|d). Moreover in most cases no data are available on P (illness|infection, d) and little is known in order to build a biologically meaningful parametric model. In most cases however, one can assume the probability P (illness|d) to share the same fundamental properties or constraints (8), (9) and (10), namely being monotone increasing from 0 to 1, when dose d varies from 0 to ∞ (see e.g. Teunis et al., 1999) . This again, even more strongly, motivates the point of view that many statistical models are biologically plausible.
Fractional Polynomials
Other more flexible models like the fractional polynomials can be competitors of the BP, LN, LL and EV commonly used models in microbial risk assessment. Unlike conventional polynomials that take on positive integer powers (up to the degree being considered), FP's use powers from a predefined set, P = {−2, −1, −0.5, 0, 0.5, 1, 2, ..., max(3, m)}, with m the degree of the FP (see below). In principle, other fractional (negative and positive) powers can be considered, but Royston and Altman (1994) illustrated that the above restricted set is sufficient for most practical purposes. The family of fractional polynomials has been shown to be useful in several other, somewhat related fields of application, see e.g. Faes et al., (2003 , Shkedy et al., (2006) , Hens et al., (2007) .
Fractional polynomials of degree m with powers p 1 ≤ p 2 ≤ . . . ≤ p m , and in the GLM framework for binary response data, are defined as
where for j = 1, . . . , m,
with p 0 = 0 and H 0 (d) ≡ 1. In (11), π denotes the probability on the adverse effect of interest (infection, illness) and g some link function (such as the logit or probit link). As shown by Royston and Altman (1994) , FP's of degree m higher than 2 are rarely needed in practice.
The FP model (11) does not automatically satisfy properties (8) (8) to (10), we do not further consider modifications of first degree FP's. Second degree FP's however can be modified to satisfy the fundamental properties as follows
for a given link function g. So, as compared to the original definition of FP's, there is no intercept, d is replaced by log(d + 1) and coefficients and powers of both terms have to be opposite in sign. The first term on the rhs of (12) guarantees property (8), while the second one guarantees property (10), and both terms are automatically monotone. We will use the typical GLM links: the logit, the probit and the complementary log-log link. In the applications and the simulations in the next sections, model (12) will be fitted by constrained maximum likelihood, to ensure that β 1 , p 1 < 0 and β 2 , p 2 > 0.
An overview of all candidate models considered in this paper and the functions to derive them are displayed in Table 1 (for all admissible powers in the set P). We include the "classical" models (Beta-Poisson, log-logistic, log-normal, and extreme-value) and the family (12) of modified fractional polynomials of degree 2 with logit, probit and complementary log-log link. Note that all models have the same degree of complexity (two parameters). This set of candidate models contains a total of M = 40 models: 4 classical models (BP, LL, LN, EV) and three times 12 FP models (for three different link functions: 3 negative powers, each combined with 4 positive powers). 
The SAS procedure NLMIXED has been used to fit all models (SAS code is available from the authors on request). To improve computational stability, the BP model is reparameterized in terms of mean and variance related parameters, using
The approach used to calculate confidence intervals for the predicted probabilities was to calculate the confidence intervals on the scale of the underlying continuous variable (i.e., on the log-odds scale or the probit scale or the cloglog scale) and the resulting upper and lower confidence bounds are then converted into probabilities using the logistic distribution, the cumulative distribution function of the standard normal distribution or a Gompertz distribution. For the BP model, which does not use any of the three link functions, the confidence intervals for the estimated parameters are obtained using a logit-based transformation (shown in the next section).
Model Averaging Approach
This section recapitulates the necessary formulae for model averaging according to Burnham and Anderson (2002) . The set of M plausible candidate models presented in Section 2 is fit to the data and the probability of infection (or illness This formulation is useful since it accounts for both the within and between model variability in estimating the variance of the averaged risk estimate.
In order to guarantee that the confidence interval for π(d) is part of the eligible (0,1) range, we first construct a confidence interval [l, u] for the logit transformed parameter logit(
) and next transform it back to the probability scale using the expit
. Since both transformations forth and back are monotone one-to-one, the coverage probability remains exactly the same (see also Burnham et al., 1987) . Using the delta-method to calculate the standard error of logit(π a )
for the construction of the interval [l, u] , the final large sample confidence interval for π(d) can be written as
Application to Data
In this section, we illustrate the use of the 36 modified fractional polynomials (12) along with the four classical models and their model average in order to estimate the risk of illness or infection. In a first study, we use data from Hornick et al., (1970) where the volunteers ingested wild-type Salmonella typhi in 45 mL of milk. When clinical illness developed, the volunteers were promptly treated with effective antibiotics to which the challenge strain was highly susceptible. The data are presented in Table 2 . It includes the dose of pathogenic Salmonella typhi, the total number of individuals exposed and the individuals who eventually became ill. Thus, in the first study we investigate the probability of illness due to Salmonella typhi in relation to the ingested dose. A second study, investigates the risk for infection due to Campylobacter jejuni (Black et al., 1988) , with the data presented in Table 3 . It includes the dose of Campylobacter jejuni, the total number of individuals exposed, the individuals infected and the individuals who eventually became ill. Both data sets are also discussed in Teunis et al. (1996) . to 0.01986. The question is on which model inference should be based. Using the Akaike information criterion, the relative importance of each model is calculated. One way is to use the estimates from a model that has AIC-weight greater or equal to 0.9 .
However, none of our models meets that criterion and it is unlikely in reality that such a model would be found. For this data example, the 5 best fitting FPs have somewhat higher weights but still far below 0.9. Instead of selecting one final model, model averaging based on all available models (or a selection) can be used. The averaged risk estimate is shown on the last line of Table 4 together with its standard errors and 95% Wald confidence intervals. The confidence intervals are wider than for individual models but this is expected because model averaging incorporates variability between competing models. This uncertainty indicates the importance of model averaging, especially at low doses where we do not have data. This uncertainty is also clearly visualised in Figure 1 . 
Campylobacter Jejuni
Applying model averaging over all 40 models on the Campylobacter jejuni data example, we obtained an averaged risk estimate, at the dose=10cfu, of to 0.21281 with a standard error equal to 0.29038 and confidence intervals from 0.00896 to 0.88986. The five best fitting models extended with the "classical" models BP, LL, LN and EV (if not included in the top 5) are shown in Figure 2 (a). This figure shows some curves with a peculiar pattern left from the data range. They can be characterised by a steep increase at low dose levels.
Based on biological knowledge or expertise such models might be considered as not plausible.
Extending the minimal set of criteria (8), (9) and (10), such models might be excluded from the initial set of candidate models as follows.
In addition to (8), (9) and (10), the constraint
controls the increase of the models in the low dose range by excluding all models which derivatives exceed a certain threshold C in the range. The choice of C depends on the particular application and should be governed by additional biological expertise. Here we illustrate this idea by applying the threshold C = 0.2 on the dose range from 1e-20 to 5 cfu (transformed to log base 10 scale). As a result 14 models are excluded and averaging is restricted to 26 models. Table 5 shows the estimated risks at a dose of 10cfu, their standard errors and 95% confidence intervals for Campylobacter jejuni. Eight models, the five best fitting models and the classical models, out of the 26 fitted models after the rule-out are shown. In this example, only small differences in AIC are seen, and all models get about the same weight. The probability of infection due to Campylobacter jejuni at a dose of 10cfu ranges from 0.0137 to 0.3236. By model averaging we obtain an averaged risk estimate of 0.089, which is about two times less than the averaged risk estimate over all 40 models. The confidence interval based on the 
Simulation Study
In a small simulation study we explore and compare the performance of the estimated risk based on three model approaches: each of the 40 candidate models individually, the best fitting model according to AIC (varying from run to run), and by model averaging. The model chosen most often by AIC across the simulations was also monitored.
A total of S = 1000 datasets were generated. For each run, we assume the same dose levels (d) and total number of individuals exposed (n) as those in the Salmonella typhi data set, and generate the number of ill individuals based on the BP model or based on a fractional polynomial EV model, with parameters based on the estimates from these models fitted on the Salmonella typhi data. In the first setting, the data sets were generated using a BP model taking parameters u = −11.8739 and v = 10.2810 in formulas (13). In the second setting, the data sets were generated using the cloglog fractional polynomial with powers (p 1 , p 2 ) = (−1, 3), as one of the best models in the Salmonella typhi example, with parameters β 1 = −18.1425 and β 2 = 22.5300 × 10 −5
. The dose response curves corresponding to both settings are shown in Figure 1 . To the 1000 generated samples, we fit the set of 40 candidate models described earlier, and estimate the risk to Salmonella typhi illness π at dose=100cfu, for each of the candidate models but also keeping track of the best fitting model according to AIC. Finally, an averaged risk over the candidate models is calculated. We summarize the performance of the different methods by reporting, across the simulations, the average variance of the estimated probability of Salmonella typhi illness (se(π * (100))) 2 using model approach * , the average length of the 95% confidence intervals and the coverage probability of these intervals. The variability of the risk estimateπ * about its average riskπ * = S s=1π * s /S over the S simulations was calculated asσ Table 6 shows the results of the first setting, which uses the BP model as the true model. has only minor influence on the estimated risk. Figure 3 helps to understand these results.
First Setting
The order of the simulation runs on the horizontal scale corresponds to the order of the corresponding point estimates. So runs leading to smaller estimates are more to the left side of the horizontal scale (as shown by the solid curve of estimates). The right upper panel of Figure 3 shows that the LN tends to overestimate the true value. The BFM (lower right panel of Figure 3 ) estimates show smaller bias and smaller variances, showing in some way its adaptive nature, but it also tends to underestimate the true value for most of the runs.
At the right end of the horizontal scale, it exhibits an extremely high variable pattern. This all combines to a very low coverage of 6.6%. The model which was chosen most often as the best model is the fractional polynomial logit-model with powers (-2,0.5). Also this model performs surprisingly poorly in terms of coverage. The averaged risk estimate, based on all considered models, shows small bias and but relatively high variance properties. But this model accounts for the variability introduced by the model selection procedure, resulting in wider confidence intervals and a coverage probability of 87% (see Figure 3 ). Actually this is also a somewhat disappointing result, but compared to all other misspecified models it is outstanding.
Second Setting
In a second setting, we study the performance of the different models and of the model selected and averaged risk estimates again, now with the FPEV (−1,3) model being the true underlying simulatin model. Results are summarized in Table 7 . In this setting, the MSE of the BP model is no longer the smallest, and also the coverage probability is very small as it underestimates the true value most of the times (see left upper panel of Figure 4 ).
Again, as expected, the data generating model FPEV (−1,3) has the smallest MSE and its coverage probability nicely reaches the nominal as expected (see right upper panel of Figure   4 ). The best fitting model has an average bias similar to that of the BP model, but again, an additional source of variability enters the estimation process. The fractional polynomial EV model with powers (-0.5,3) is chosen most often as the best model but as in the previous setting it exhibits a very low coverage, partly also reflecting a similarly low coverage for the BFM. The averaged risk estimate has a small bias combined with a larger variance leading to a coverage probability of 97.90.
Both simulation settings show that model averaging has a beneficial effect in reducing bias, in accounting for the variability induced by the model selection process, and consequently in better coverage characteristics. In the philosophy that a true and correct model does not exist, or that you will never know it exactly (which seems the only realistic situation), this simulation also shows that not just one single model is appropriate to describe the dose-response relationship of microbial risks, but there exists a whole set of possible models.
Fractional polynomials are very flexible to estimate the low-dose risk. However, the model selection procedure induces extra variability that should be accounted for. The averaged risk estimate gives larger weights to better-fitting models, resulting in a smaller bias. The model selection uncertainty is accounted for in this approach, and a better coverage probability obtained as illustrated in Figure 4 . However, from both simulation settings it was became evident that for this particular risk assessment application the coverage percentages for most of the model fall far below the chosen level of confidence (0.95). The magnitude of inflation of the coverage was certainly surprising to us and is in itself a clear warning to be very careful about 2.5 times from not including them.
For the first simulation setting, with the restricted set one, the true risk estimate was captured in 38.5% of the runs by the confidence intervals of the averaged risk compared to 87.1% for set two. Also, the square bias and the variance were higher for set one models than for set two models. In the second simulation setting, averaging over the four models attained a coverage probability of 87.3% versus 97.9% for set two. To this end, we see that using the richer set two, which includes the flexible fractional polynomial models, yielded coverage probabilities closer to the nominal 95% level, less biased and more precise risk estimates than set one.
Discussion
In quantitative risk assessment for microbial pathogens, dose-response assessment is a critical issue. It must be included, health effects are the end-point in any risk assessment. Data are scarce, however. Only few pathogens have been used in clinical studies, and even these have been done on a small scale with few volunteers exposed per dose, due to the high costs involved. As a consequence, microbial dose-response data often do not contain a great deal of information on the shape of the dose-response relation, and model choice based entirely on experimental data is not feasible (Teunis and Havelaar 2000) . This problem has raised may discussions and several solutions have been proposed. One could use animals, as these allow, at least in principle, collection of more extensive data sets. However, this paper also has demonstrated that this may merely give a better insight into the variability involved, not necessarily decreasing the uncertainty about the shape of the relation. Model averaging has been used before, weighting over an arbitrary collection of mathematical relations considered useful. Reasons for inclusion may range from biological plausibility to flexibility or mere tradition (like threshold models). Here it has been shown that fractional polynomials can be derived from the general equation (3) thereby potentially extending the family of eligible models a great deal, and providing a natural choice for the collection of models to include in model averaging.
As observed in the simulation study, the coverage probabilities of the confidence intervals of the individual models, the best fitting models and the model average highly depend on the generating (true) model. When bias values are high relative to the variance, the coverage of these intervals considerably fall below the nominal level of confidence. The bias values for the averaged risk were 10 times higher when only averaging over the four commonly used doseresponse models than when fractional polynomials were included and as a result the coverage probabilities in the former case were always below nominal. Our findings corroborate with the findings of Wheeler and Bailer (2007) . Though Wheeler and Bailer (2007) employed model averaging based on the "average-model" versus the "average-risk" method that we use, they pointed out the importance of an adequate model space. In their extensive simulation study involving the 3-model space of flexible models (the weibull, the multistage and the log-probit) and the 7-model space covering the quantal linear, quantal quadratic, the logistic and the probit models in addition to those in the 3-model space, they conclude a better performance, in terms of bias and coverage across most simulations conditions, for the three-model space than for the seven-model space. Therefore, the consideration of more flexible models in applying model averaging to risk assessment is an issue that can be extended with the set (or biologically more plausible subset) of the modified fractional polynomials that we propose in this paper.
An essential improvement in dose-response assessment is its extension to a hierarchical framework: like most biological problems, data can frequently be organized hierarchically. For example several isolates (pure strains of microorganisms separated from a mixed bacterial culture) of a single pathogen species in the same host species, different but related pathogen species in the same host, or a single pathogen isolate in hosts with different levels of immunity. As the purpose of risk assessment usually is to predict risks for an exposed population, dose-response relations should be translated from the special, experimental setting to a more general, unspecified situation. For instance, given the different responses to a limited collection of isolates of a pathogen, what would be the response to a newly isolated specimen, of the same type? Fixed effects models are easy to implement and represent a first solution, but the random models, although more complex, use all available data and are more suitable for explicative studies. The generalized linear mixed models (Agresti, 2002; Molenberghs and Verbeke, 2005) allow prediction by using the (joint) distribution of the random parameters to make exactly this generalization. Our future interest is to extend these proposed fractional polynomials to investigate dose-response relationships between isolates of a single pathogen using generalized linear mixed models.
Further research is needed to go into some issues, like the estimation at very low dose levels, especially in case of limited information. Since low dose extrapolation is crucial in risk assessment and the AIC method selects a model regardless of its intended use, we wish to further investigate selecting a model looking at the (lower dose) region of interest, by using e.g. the focused information criterion (Claeskens and Hjort 2003) .
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